Correspondence: Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study

J Thorac Oncol. 2023 Oct;18(10):e105-e106. doi: 10.1016/j.jtho.2023.05.026.

Authors

Ting-An Lin¹, Ssu-Yu Chen¹, Renin Chang², Cheuk-Kwan Sun³

Affiliations

¹ School of Medicine, Chung Shan Medical University, Taichung City, Taiwan.
² Department of Emergency Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.
³ Department of Emergency Medicine, E-Da Dachang Hospital, I-Shou University, Kaohsiung City, Taiwan; School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung City, Taiwan. Electronic address: lawrence.c.k.sun@gmail.com.

PMID: 37758344
DOI: 10.1016/j.jtho.2023.05.026

No abstract available

Publication types

Letter
Comment

MeSH terms

Chemoradiotherapy
Cohort Studies
Esophageal Neoplasms* / drug therapy
Esophageal Squamous Cell Carcinoma* / therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Lung Neoplasms*
Propensity Score
Retrospective Studies

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors